Expected Rebound in Elective and Medically Necessary Procedures

Expected Rebound in Elective and Medically Necessary Procedures

Rafi Musher • May 26, 2020
Rafi Musher • May 26, 2020

Share

Stax's short term outlook (1-6 month) across the healthcare sector.

Many healthcare companies have similar questions about return to patient volumes, which locations will see a return to procedures, and the long-term prognosis for healthcare. To facilitate the process and speed up the effort, Stax has initiated new field research on expectations for return to procedures and developed a fast framework to help management teams, boards of directors, and investors determine the short, medium, and long- term implications for healthcare and their particular organizations.


The process is informed by 20 years of providing healthcare leaders with insights for strategic operating and investment decisions. It is inclusive, iterative, data-rich, and can be done remotely.


With a 20+ year record of successfully modeling healthcare volumes, supply and demand, and competitive market dynamics across the spectrum of providers, we know how public and private spend can be modeled to help forecast overall patient volumes nationally and locally. We have a range of traditional and creative datasets at our fingertips and understand how to conduct large-scale primary research with consumers, healthcare professionals, and providers. Healthcare choices are complex, and there is a tremendous amount of data to bring together and model to provide strong parameters on patient volumes and market share potential, for management teams and investors for the short and long term.




Contact Us

Read More

Grant Thornton Stax Advises Thoma Bravo on Merger of Hypergene & Stratsys
December 19, 2025
Grant Thornton Stax recently supported Hypergene, a portfolio management solutions backed by Thoma Bravo, on its recent merger with Stratsys. Read about the deal here.
Grant Thornton Stax Community ERG Unites to Give Back
December 17, 2025
Our teams across the US offered to spread some holiday cheer, rallying together to donate toys to local charities. Read about our various efforts, as well as charities you can donate to.
Grant Thornton Stax Sell-side: Pairsoft Investment by TA Assoc.
December 17, 2025
Grant Thornton Stax supported Pairsoft, a leading provider of procure-to-pay automation and payment solutions, on its recent majority growth investment by TA Associates. Read more.
Grant Thornton Stax Sell-side Support: Moss Acquisition by Vomela
December 17, 2025
Grant Thornton Stax recently supported Moss, a global producer of innovative brand experiences, on its acquisition by Vomela, a Riverside Company. Read more about the deal here
Will Barden Named Among The Consulting Report’s Top 25 Strategy Leaders of 2025
By Will Barden December 11, 2025
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
Investing in Pharma Technology: A Healthcare Breakfast Discussion
By Rob Larson & Jordan Abrams December 8, 2025
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Show More